Sculptra and Radiesse are different injectable products often discussed as collagen biostimulators. Sculptra contains poly-L-lactic acid (PLLA), while Radiesse contains calcium hydroxylapatite (CaHA) in a gel carrier. (Sculptra U.S. instructions for use、U.S. product information; Radiesse U.S. instructions for use) If you are comparing them in Tokyo, ask how each proposed treatment relates to your goal, treatment area, medical history, and follow-up needs. A useful comparison covers the exact product, expected changes, risks, appointments, and total cost, with Japanese regulatory status confirmed separately from information published for other countries.
The question “Which is better?” becomes more useful when you add “for what?” Improving a particular contour and addressing a broader skin-quality concern are different goals. Two proposals may use different products because they are trying to achieve different changes.
This guide extends NERO’s overview of aesthetic treatment options in Japan, focusing on the questions that help you compare biostimulator proposals.
What Are Sculptra and Radiesse?
Sculptra is a PLLA injectable that is reconstituted before use. Its U.S. product information describes a gradual treatment effect. Radiesse is supplied as a CaHA-based injectable implant in a gel carrier. (Sculptra U.S. instructions for use、U.S. product information; Radiesse U.S. instructions for use)
The term “biostimulator” describes an intended biological effect; it does not make the products identical. Product formulation, treatment area, preparation, and injection technique remain important.
| Point of comparison | Sculptra | Radiesse |
| Principal material | Poly-L-lactic acid, or PLLA | Calcium hydroxylapatite, or CaHA, in a gel carrier |
| Product preparation | Reconstituted before injection | Supplied in a syringe; confirm whether dilution is proposed |
| Important clarification | Ask how a gradual response will be assessed | Ask whether the plan aims at volume, contour, skin quality, or a combination |
| Information to confirm in Tokyo | Exact product, proposed use, local regulatory status, and follow-up | Exact version, proposed use, local regulatory status, and follow-up |
Product descriptions are based on U.S. manufacturer documents. They do not establish approval or suitability for a proposed treatment in Japan. (Sculptra U.S. instructions for use、U.S. product information; Radiesse U.S. instructions for use)
For additional context, read NERO’s Sculptra background guide.
For a broader overview of injectable treatment categories, compare skin-booster and biostimulator categories.
Compare the Goal Before Comparing the Brand
Start with the change you want to discuss. For example: “My cheeks look less full than before,” or “I want to understand what is affecting my lower-face contour.” These descriptions help the clinician assess your concerns and explain the options.
Ask which part of the concern the proposed injectable is expected to address. If the explanation includes words such as “lifting,” “firmness,” or “rejuvenation,” ask what those terms mean in your plan. Which area would be treated, and what change would be used to judge the response?
Also ask what the treatment is unlikely to change and what alternatives are relevant. A consultation may lead to a different product, a different treatment category, or a decision to postpone treatment.
If one proposal targets a specific contour and another targets a broader area, clarify that difference before comparing their prices or treatment photographs.
Check the Exact Product and the Evidence Behind the Proposal
Ask the clinic to name the product in writing, including its version. Radiesse and Radiesse (+), for example, have separate product information; Radiesse (+) includes lidocaine. (Radiesse and Radiesse (+) U.S. product and safety information)
For any proposed use, ask what evidence supports the intended treatment area and technique. A study of one area or preparation does not automatically answer questions about another.
Check which country each approval claim refers to. “FDA approved” refers to the United States and specific approved uses. It does not establish Japanese approval or cover every technique a clinic might offer. Ask the clinic to explain the exact product’s status in Japan and whether the proposed use falls within the applicable approved indications.
An answer should distinguish product information, clinical evidence, and the clinician’s reasoning for your case. These are related, but they answer different questions.
For a fuller framework, read NERO’s checklist for comparing aesthetic technology claims.
Ask How Results and Further Treatment Will Be Reviewed
A treatment proposal should explain when the clinician intends to review the response and what that review will involve. Ask which changes may be visible early, which require more time to assess, and how further treatment decisions will be made.
Avoid judging a plan solely by an advertised duration. Ask what the cited time period measures, which treatment area it relates to, and whether it describes a study result or an expectation for your own care.
Clarify the proposed number of appointments, the estimated amount of product, and whether later sessions are provisional. You should also understand whether the quote covers the initial treatment only or includes review and any additional sessions.
If you are asked to pay before the full plan is settled, read NERO’s guide to written treatment plans and deposit terms.
For international visitors, these details affect whether the plan is practical. Tell the clinic your departure date before committing to a course of treatment.
Understand Risks and What Happens if There Is a Problem
Injectable fillers can cause swelling, bruising, pain, infection, and lumps. Delayed reactions are possible. Rare vascular complications can cause tissue injury, vision loss, or stroke. (Dermal Fillers (Soft Tissue Fillers))
Ask about the risks of the exact product and treatment area, the injector’s relevant experience, and the clinic’s response to complications. Also ask what options exist if a result needs correction. The FDA notes that removing non-HA filler materials may be difficult or impossible. (Dermal Fillers (Soft Tissue Fillers))
Before treatment, obtain a contact number and clear instructions about symptoms requiring urgent assessment. Unusual pain, changes in vision, or white, gray, or blue skin near an injection site require immediate medical attention. (Dermal Fillers (Soft Tissue Fillers))
If you are returning home, clarify how the clinic would coordinate advice or records with a local clinician. An online follow-up arrangement should explain when an in-person examination is needed.
A Checklist for Comparing Two Proposals
Use the same fields for each consultation. If information is missing, ask for clarification before treating the proposals as comparable.
| Comparison point | What to record for each proposal |
| Goal and area | The specific concern and the areas to be treated |
| Product | Full product name, version, and planned preparation |
| Reason for the choice | Why the clinician considers this option relevant |
| Evidence and regulatory explanation | The supporting information and its country-specific scope |
| Expected benefit and limits | The changes discussed and what the treatment will not address |
| Review and further sessions | When response will be assessed and how later decisions will be made |
| Total estimated cost | Product, treatment, consultation, review, and any additional fees |
| Risks and follow-up | Written instructions, contact details, and care after departure |
This table helps you identify differences in the explanations. It cannot determine which product is suitable for you.
Six Questions to Take to Your Consultation
- What specific change are you proposing, and which areas would you treat?
- Why are you considering this product rather than another option?
- What exact product and preparation would you use?
- What evidence and Japanese regulatory information apply to this proposal?
- What risks, total costs, and review appointments should I understand?
- What happens if I need further assessment or care after leaving Japan?
Frequently Asked Questions
Is Sculptra better than Radiesse?
There is no universal answer. Ask a qualified clinician to explain how each option relates to the findings from your examination, goals, treatment area, and ability to attend follow-up.
Are they the same as hyaluronic acid fillers?
No. Sculptra is PLLA-based and Radiesse is CaHA-based. (Sculptra U.S. instructions for use,U.S. product information; Radiesse U.S. instructions for use) Ask how the proposed material affects the treatment plan and options for managing an unwanted result.
Does FDA approval mean a product is approved in Japan?
No. U.S. approval and Japanese regulatory status must be assessed separately. Confirm the exact product and proposed use with the clinic.
Can I have treatment during a short visit to Tokyo?
That depends on the assessment and follow-up requirements. Share your itinerary and ask which appointments must take place in person before agreeing to treatment.
Choose Your Next Step With a Clearer Comparison
You should leave a consultation knowing what is proposed, why it relates to your concern, and how the response will be reviewed. Those details make a comparison between Sculptra and Radiesse more useful than a brand preference alone.
For a wider view of the available categories, return to NERO’s guide to comparing aesthetic treatment pathways in Japan.
| ・This website provides general knowledge about aesthetic medicine from a neutral perspective as much as possible. Please note that the information is not intended to encourage self-diagnosis. Be sure to check the official website of the clinic and consult each medical institution for details regarding treatment. ・This article is based on information available at the time of writing and publication. Please check the official website for the latest updates. ・If cosmetics or massage-related content is mentioned, it is not within the scope of medical supervision. |
